Financials
Income statement
Fiscal date | May 2024 | Feb 2024 | Nov 2023 | Aug 2023 |
---|---|---|---|---|
Total reported revenue | 14.5B | 14.4B | 7.1B | 9.8B |
Cost of revenue | 11.0B | 10.9B | 5.6B | 7.0B |
Gross profit | 3.6B | 3.6B | 1.5B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.6B | 1.8B | -422M | 1.1B |
Non operating interest income | ||||
Income | 35M | 118M | -298M | 187M |
Expense | 12M | 3M | 3M | 6M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 2.0B | -133M | 1.5B |
Tax provision | 541M | 679M | -233M | 472M |
Net income | 1.4B | 1.3B | 100M | 1.1B |
Basic EPS | — | 48.7 | — | — |
Diluted EPS | — | 48.7 | — | — |
Basic average shares | — | 27.1M | — | — |
Diluted average shares | — | 27.1M | — | — |
EBITDA | 2.0B | 2.0B | -102M | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |